Table 1.
Examples of studies using nanocarriers to passively target TAM.
Carrier Type | Cargo | Model | Purpose | Ref. |
---|---|---|---|---|
Liposomes | Simvastatin | B16.F10 murine melanoma | Improve efficacy of statins using a tumor targeted delivery system | [119] |
Alendronate and doxorubicin | Multiple murine cancer models | Increase anti-tumor efficacy by co-delivery of alendronate and doxorubicin | [117] | |
Acetylated CMC | Docetaxel | PAN02 pancreatic cancer xenograft | Targeted depletion of stroma | [123] |
Linear cyclodextrin-based nanoparticle | Fluorescent label | Murine GL261 glioma | Macrophage and microglia targeting | [125] |
Iron oxide nanoparticle | - | Murine breast cancer using MMTV–PyMT cells | Evaluate intrinsic therapeutic effects of USPIO | [128] |
Red blood cells | Bisphosphonates | Normal Swiss, C57BL/6 and Balb/C mice | Macrophage depletion | [130,131] |
High-density lipoprotein-based nanoparticle | Radiolabel | Murine 4T1 breast cancer | Imaging of TAM | [134] |
Cowpea mosaic virus | Fluorescent label, Photosensitizer | RAW264.7 macrophages and B16F10 tumor cells | TAM and tumor cell targeting | [135,136] |
PAMAM dendrimers | Fluorescent dye | Rat 9L gliosarcoma | Cross BBB and achieve homogenous tumor distribution | [126] |
Carbon nanotubes | Fluorescent dye | Murine GL261 glioma | Study uptake and toxicity | [138] |
CpGs | Murine GL261 glioma | Evaluate CNT as a delivery vehicle | [139,140] | |
Albumin-paclitaxel conjugate | Paclitaxel | Murine KPC pancreatic ductal adenocarcinoma | Investigate new mechanism for Abraxane effectiveness | [146] |
Mesoporous silicon particles loaded with albumin–paclitaxel conjugate | Paclitaxel | Murine 4T1 breast cancer and murine 3LL lung cancer | Redirect nab-paclitaxel to liver metastasis | [147] |
Abbreviations: BBB: blood brain barrier, CMC: carboxymethylcellulose, USPIO: ultrasmall superparamagnetic iron oxide, PAMAM: poly(amidoamine), CNT: carbon nanotubes, CpGs: oligodeoxynucleotides containing CpG motifs.